GlassScriptPhysician profile
Sara Ocheltree
NPI 1871937151
$1,029.20
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $312 · 2023: $379 · 2024: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $529.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $173.97 | 2019-2023 | Jardiance |
| Genentech USA, INC. | $99.99 | 2019 | |
| Alnylam Pharmaceuticals INC. | $82.45 | 2023-2024 | Amvuttra |
| Janssen Pharmaceuticals, INC | $78.72 | 2023 | Xarelto |
| Kestra Medical Technology Services, INC. | $66.34 | 2023 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $54.94 | 2020-2023 | Farxiga |
| Glaxosmithkline, LLC. | $51.42 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $50.95 | 2023-2024 | Uptravi, Opsumit |
| Novartis Pharmaceuticals Corporation | $45.38 | 2023 | |
| Advanced Respiratory, INC | $39.44 | 2020 | |
| Genzyme Corporation | $34.32 | 2019-2020 | |
| Irhythm Technologies, INC. | $33.64 | 2024 | Zio Xt Patch, Zio Monitor |
| Teleflex LLC | $33.42 | 2024 | Quikclot |
| Regeneron Healthcare Solutions, INC. | $26.83 | 2020 | |
| Grifols USA, LLC | $24.13 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $23.61 | 2020 | |
| Jazz Pharmaceuticals INC. | $22.21 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.48 | 2023 | Lifevest |
| Amgen INC. | $20.31 | 2024 | Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $17.06 | 2023 | |
| Kiniksa Pharmaceuticals, LTD. | $14.60 | 2023 | Arcalyst |
| Mylan Specialty L.P. | $13.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Ocheltree listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.